Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D

A Q&A with iXCells Biotechnologies CEO, Steve Smith

1

Induced pluripotent stem cell (iPSC)-derived models enable earlier drug discovery by aligning research with human biology.
2

iPSCs enhance preclinical insights, allowing for more accurate target validation and reducing false positives in drug development.
3

Standardized platforms for iPSC models ensure consistency and reliability, supporting better decision-making in rare disease research.
4

iPSC models capture patient-specific biology, addressing the variability in rare diseases and improving therapeutic relevance.
5

Projects like Project Mosaic illustrate how iPSC models can identify disease subtypes and inform precision medicine strategies.

1